is bpc-157 fda approved panel votes to place popular peptide on compounding list FDA commitee votes 8-6 to

Anti-Inflammatory and Cytokine Regulation BPC-157 downregulates pro-inflammatory mediators including: Tumor Necrosis Factor-Alpha (TNF-) Interleukin-1 Beta (IL-1) Interleukin-6 (IL-6) Leukotrienes key drivers of pain and inflammation in arthritis and tendinopathy Growth Hormone Receptor Upregulation Emerging research suggests BPC-157 increases growth hormone receptor density in injured tissues, amplifying the natural repair signals that decline with age or chronic inflammation

Handling Notes Keep away from light

Guidelines for multi-dose vials and safe needle disposal

Leaving your vial on the counter, even overnight, can significantly reduce potency